Zimmer Partners’s Pulmonx LUNG Stock Holding History

Zimmer Partners’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,000	Closed	-$915K	–	200
2021 Q1	$915K	Hold	20,000	–	–	0.01%	143
2020 Q4	$1.38M	Buy	+20,000	New	+$979K	0.02%	104

Other funds holding LUNG

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Zimmer Partners's LUNG Position: Q2 2021 in Review

Zimmer Partners sold out of Pulmonx (LUNG) in Q2 2021, closing a stake of 20,000 shares — an estimated $915K sold.

Zimmer Partners first reported a position in LUNG in Q4 2020 and held it in 2 quarters. The position peaked at $1.38M in Q4 2020. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2021.

Zimmer Partners reported no remaining Pulmonx position as of Q2 2021 after selling out during the quarter.
Zimmer Partners sold 20,000 Pulmonx shares in Q2 2021, an estimated $915K.
Zimmer Partners first reported a position in Pulmonx in Q4 2020 and held it in 2 quarters.
Zimmer Partners's Pulmonx position peaked at $1.38M in Q4 2020.
113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2021.

Based on Zimmer Partners's 13F filing for Q2 2021, filed 16 Aug 2021.